CoChat

LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas

Open access
Zhang, Yong, Roccaro, Aldo M., Rombaoa, Christopher, Flores, Ludmilla, Obad, Susanna, Fernandes, Stacey M., Sacco, Antonio, Liu, Yang, Ngo, Hai, Quang, Phong, Azab, Abdel Kareem, Azab, Feda, Maiso, Patricia, Reagan, Michaela, Brown, Jennifer R., Thai, To-Ha, Kauppinen, Sakari, Ghobrial, Irene M. · 2012 · Blood
Cited by 150

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

miR-155 acts as an oncogenic miR in B-cell lymphoproliferative disorders, including Waldenstrom macroglobulinemia (WM) and chronic lymphocytic leukemia, and is therefore a potential target for therapeutic intervention. However, efficient targeting of miRs in tumor cells in vivo remains a significant challenge for the development of miR-155–based therapeutics for the treatment of B-cell malignancies. In the present study, we show that an 8-mer locked nucleic acid anti–miR-155 oligonucleotide targeting the seed region of miR-155 inhibits WM and chronic lymphocytic leukemia cell proliferation in vitro. Moreover, anti–miR-155 delivered systemically showed uptake in the BM CD19+ cells of WM-engrafted mice, resulting in the up-regulation of several miR-155 target mRNAs in these cells, and decreased tumor growth significantly in vivo. We also found miR-155 levels to be elevated in stromal cells from WM patients compared with control samples. Interestingly, stromal cells from miR-155–knockout mice led to significant inhibition of WM tumor growth, indicating that miR-155 may also contribute to WM proliferation through BM microenvironmental cells. The results of the present study highlight the therapeutic potential of anti–miR-155–mediated inhibition of miR-155 in the treatment of WM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2012-02-410647

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 150

Metadata

Authors
Zhang, Y., Roccaro, A. M., Rombaoa, C., Flores, L., Obad, S., Fernandes, S. M., Sacco, A., Liu, Y., Ngo, H., Quang, P., Azab, A. K., Azab, F., Maiso, P., Reagan, M., Brown, J. R., Thai, T.-H., Kauppinen, S., & Ghobrial, I. M.
Venue
Blood
Published
2012-08-23
Volume
120
Issue
8
Pages
1678-1686
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2155518647
Cited by
150
References
7
FWCI
5.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas. https://app.cochat.ai/papers/10.1182/blood-2012-02-410647
The paper
Zhang, Y., Roccaro, A. M., Rombaoa, C., Flores, L., Obad, S., Fernandes, S. M., Sacco, A., Liu, Y., Ngo, H., Quang, P., Azab, A. K., Azab, F., Maiso, P., Reagan, M., Brown, J. R., Thai, T.-H., Kauppinen, S., & Ghobrial, I. M. (2012). LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas. Blood. https://doi.org/10.1182/blood-2012-02-410647

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.